Objective: To evaluate fractures and falls in epilepsy patients taking antiepileptic drugs (AED) and to assess their awareness of AED-related bone health, falls, and fracture risk.
Antiepileptic drugs (AEDs) have a negative impact on bone health, [1] [2] [3] [4] balance function, 5, 6 and falls and fracture risk. [7] [8] [9] [10] Meta-analyses confirm an association between AED use, reduced bone mineral density (BMD), and increased fracture risk, 11, 12 which may result from AED-related bone fragility, seizure-related accidents, or a greater propensity to fall due to balance impairments. The proportion of fractures reported to be seizure-related in epilepsy patients varies (25% to 43%). [13] [14] [15] A recent population-based study showed an increased risk of nontraumatic fractures in older AED users. 16 Our group, 2 and others, 17 found that BMD correlated inversely with AED therapy (polytherapy, therapy length) and epilepsy status (generalized seizures). Whether these adverse effects are a consequence of either epilepsy or AED treatment is uncertain.
In AED users, non-seizure-related falls may have various causes including drug-related dizziness and ataxia. 18 Few studies have evaluated both falls and fracture history in a cohort of epilepsy patients chronically treated with AEDs, and whether the fall or fracture was seizure-related. Often, fall circumstances are poorly documented.
No previous study has reported patients' knowledge and attitudes about AED use affecting bone health. This information may enable clinicians to better meet the needs of AED-treated patients.
This study aimed to determine the prevalence and circumstances of reported falls and fractures, and contributory risk factors, in a population of AED-treated epilepsy patients, and in a comparison sample; and to identify the awareness of epilepsy patients concerning AED treatment, bone health, and risks of falls and fractures.
METHODS Standard protocol approvals, registrations, and patient consents. Melbourne Health Human Research Ethics Committee (HREC) approved the study (HREC2009.239) and participants provided written informed consent. Data for comparison were obtained from our database of HREC-approved studies conducted through the Department of Medicine, Royal Melbourne Hospital (RMH), in which all participants provided written informed consent (including HREC2003.249, 2002.232, 0824/98).
Recruitment. AED users. Inclusion criteria for AED users
were epilepsy patients age Ն16 years, taking AEDs for Ն3 months, ambulating independently, and attending outpatient epilepsy clinics at the RMH, Melbourne Australia, between August 2009 and March 2010. The RMH Epilepsy Program is a referral center, staffed by neurologists with subspecialty training in epileptology assisted by fellows and junior medical staff, for management of patients with epilepsy and related disorders. Referrals come from various sources, including general practitioners, other specialists, and the Emergency Department. The full spectrum of epilepsy severity and duration are seen, from newly diagnosed through to chronic drug-resistant cases.
Potential participants were recruited through a systematic sampling approach. Every second or third patient on each clinic attendance list was asked in the waiting room if they had epilepsy previously diagnosed by a neurologist, and if so, was invited to participate in the study. The starting point within each attendance list was chosen randomly each clinic session. Epilepsy syndrome diagnoses, if uncertain, were confirmed via medical records, EEG, and MRI reports.
Exclusion criteria included new or undiagnosed patients; cognitive impairment; prolonged treatment with non-AED medications affecting bone metabolism (e.g., corticosteroid); chronic active illness (e.g., active cancers, chronic liver or kidney disease); language barriers with no interpreter available; and underlying bone diseases, except osteoporosis, as it is a potential outcome of AED therapy and is of central interest in this study.
Non-AED users. Data on falls and fracture history for comparison were obtained from our database of existing studies, including a twin study investigating balance, gait, and strength. 19 To maintain independence between controls, if a twin was selected their cotwin was excluded.
Of 4,484 subjects within our database, 1,140 subjects (F ϭ 951, M ϭ 302) without any history of epilepsy, AED exposure, or attending the epilepsy clinic were selected for the control matching if they otherwise met the same selection criteria as AED users.
Selected potential nonuser controls (n ϭ 1,140) were matched with AED users (n ϭ 150) using a method to optimize age matches in Microsoft Access. Each AED user in turn was compared with potential controls listed in random order, seeking the first same-gender, exact age match, whereupon the matched control was withdrawn from the pool of potential controls. For every user the initial match search was within the reducing pool. For users not matched to any control by exact age, a broader age match was sought via further cycles of age matching by Ϯ1, 2, and 3 years. Initially limited to finding 1 match per user, the 4 age-stepped cycles were repeated 3 times for all users against the diminishing pool of unmatched nonusers, sequentially allowing a limit of 2, 3, and a maximum of 4 unique nonuser matched controls per user.
The matching identified 314 female nonuser matched controls, all with fracture data recorded, but only 76 having falls data available. Fall analyses were performed between the group of nonusers (n ϭ 76) and their matched female users (n ϭ 78) for whom we had falls data. Male nonuser matched controls (192) were identified, all having fracture data, but too few having falls data available for analysis. Falls data for many nonusers were unavailable, having not been collected in their original studies.
Data collection.
Participants completed a 30-minute written self-report questionnaire, with researcher assistance (B.S.A.). Important data on epilepsy history and diagnosis, illness, and medication history were supplemented by reference to the patient's medical records where the data were uncertain. Epi- Table 1 Baseline characteristics of participants lepsy syndromes were classified according to the neurologists' diagnoses based on the International League Against Epilepsy classification. 20 Questionnaire. The questionnaire included demographic data, epilepsy history, history of AED use, other medication, medical comorbidities, family history of osteoporosis, history of falls and fractures, and knowledge relating to AEDs, falls, and bone health.
Fracture ascertainment and history. Fracture history was self-reported as seizure-related or non-seizure-related. For possible seizure-related fractures, detailed data sought included the presence of witnesses, and treatments including x-ray imaging. Fractures were categorized into major 21 and less common sites 22 for osteoporotic fractures. Fractures occurring with a fall from standing height or less (excluding seizures), and with minimal trauma other than falling, were considered low-trauma fractures. Moderate-to-high trauma fractures included those resulting from falls from greater than standing height, assaults, and from motor vehicle accidents. Participant groups were analyzed for their lifetime prevalence (site-specific) of fracture, and for fracture history during AED therapy in AED users.
History of falls. A fall was defined as "a sudden, unintentional change in position causing an individual to land at a lower level, on an object, the floor, or on the ground." 23 AED users listed their seizure-related and non-seizure-related falls in the preceding year, including details of circumstances and consequences of each fall, up to a maximum of 4 falls. This maximum was applied due to limitations of time to collect extended data, limited detailed recollection for multiple falls, and statistics of less common events. Users were categorized according to the number of non-seizure-related falls in the preceding year, either as 1) nonfaller or once-only faller, the latter being reported as more closely related to nonfallers than recurrent fallers, 24 or 2) 2 or more falls.
Statistical analysis. SPSS 17.0 for Windows was used. Categorical data were analyzed between groups using 2 , and continuous data using independent t tests or the Mann-Whitney U (MWU) test. Multivariate logistic regression analysis was used to examine factors associated with fractures, examining odds ratios (OR) and 95% confidence intervals (CI). Level of significance was set at 0.05 for all tests.
RESULTS
Demographics. Participants' demographic data and comorbidities are detailed in table 1. Compared to the user group, the non-AED user group had a significantly higher proportion of females than males ( p ϭ 0.035), significantly less medical illnesses, but no significant age difference ( p ϭ 0.097). These potential confounding factors (age, gender, medical illnesses, other non-AED medications) were adjusted for in our analysis. AED users. A total of 201 patients were approached and 150 participated. Thirteen (6.5%) declined and 38 were excluded (stopped using AED or had a diagnosis other than epilepsy [12] ; cognitive impairment [9] ; wheelchair mobility [8] ; interpreter not available [7] ; blindness [1] ; psychological incapacity [1] ). Medical records were accessed to ensure data accuracy or completeness for 99 participants.
To examine for selection bias, descriptive data for all patients visiting RMH epilepsy clinics in another 1-month period (111 male, 100 female) were compared with our epilepsy patient cohort. No significant differences were found in age or gender ratio ( p Ͼ 0.05). Seizure frequency and treatment profile details were not compared.
Clinical characteristics and AED usage are detailed in table e-1 on the Neurology ® Web site at www.neurology.org.
Non-AED users. A total of 506 non-AED users were selected as controls. Each female AED user was . Univariate analysis showed that during therapy, age (p ϭ 0.032), increased therapy duration (p ϭ 0.001), and AED polytherapy (p ϭ 0.007) were associated with increased fracture risk (table 3) . Multivariate analysis revealed that only therapy duration independently predicted increased risk for fractures. With every year of AED use the comparative odds of fractures increased by 4%-6%, with an estimated increase of 40% in odds for any fracture (OR 1.40, CI 1.02-1.91, p ϭ 0.036) and 60% for seizure-related fractures (OR 1.63, CI 1.10 -2.37, p ϭ 0.026) per decade of therapy.
Falls. AED users. In the preceding year, 68 (45%; 37 female, 31 male) had at least 1 fall of any cause: 45 (30%; 24 female, 21 male) had a non-seizure fall including 23 (15%) with 1 fall and 22 (15%; 14 female, 8 male) with recurrent falls, and 37 (25%) had a seizure-related fall comprising 12 (8%) with 1 fall and 25 (17%) recurrent falls. The cumulative total of non-seizure falls approximated that of seizure-related falls (table 4) . Gender, age, therapy duration, or AED polytherapy did not differ between users having no or 1 non-seizure fall, or frequent falls ( p Ͼ 0.05).
Falls in AED users taking antidepressants. AED users reported a higher prevalence of anxiety or depression and antidepressant use than nonusers (table 1). Of 29 (19%) users taking antidepressants, 10 (35%) reported non-seizure recurrent falls in the preceding year, with a total of 60 non-seizure falls (28 with 36 falls, 1 with 24 falls). Among 121 (81%) users not taking antidepressants, only 12 (10%) reported recurrent non-seizure falls ( 2 ϭ 9.402, p ϭ 0.002), with 59 falls in total, which is significantly different (MWU, z value ϭ Ϫ2.829, p ϭ 0.005), even after excluding the user with 24 falls (MWU, z value ϭ Ϫ2.400, p ϭ 0.016).
Non-seizure falls in female AED users and nonusers. Of 76 female nonusers, 13 (17%) reported falling, with a cumulative total of 27 falls in the preceding year, compared with the 78 users in whom 24 (31%) reported falling with a total of 79 falls, almost 3 times more falls. Female users had a higher rate of falls (31% of users vs 17% of nonusers, MWU, z ϭ Ϫ2.208, p ϭ 0.027) and recurrent falls (18% of users vs 5% of nonusers, 2 ϭ 4.835, p ϭ 0.028). AED use affecting falls, fracture risk, and bone health. Fewer than 30% of AED users reported Table 3 Fractures during AED therapy in all users (n ‫؍‬ 150) awareness of the increased risk for falls, fractures, decreased BMD, or a negative influence on bone metabolism with AED use. Thirty-four patients (23%) knew that most fractures in epilepsy patients were non-seizure-related. Overall, 105 (70%) patients wanted to know more about AED-related bone and balance effects.
Awareness of

DISCUSSION
This study yielded new, clinically relevant information relating to fracture risk and falls in epilepsy patients taking AEDs. AED users had a significantly higher prevalence of fracture episodes, and an increased risk of fractures at spine, clavicle, and ankle sites compared to nonusers. Increasing duration of AED treatment increased the risk for fractures. During treatment, non-seizure-related fractures, particularly low trauma fractures, were more prevalent than seizurerelated fractures. Non-seizure falls were more frequent than seizure falls in users in the preceding year. Among females, a significantly higher proportion of users had non-seizure falls and multiple falls than nonusers. Our cohort of AED users were ethnically mixed, ambulatory, noninstitutionalized patients of both genders from an adult tertiary care setting. Our findings could be most relevant to patients receiving specialist-based epilepsy management. The descriptive data of this cohort closely approximated that of the overall patient population from which our sample was drawn, although we did not compare their epilepsy history and treatment profile. In this study, 59% of AED users had 2 or less seizures in the preceding year, 43% being seizure-free, indicating that most of the cohort did not have poorly controlled epilepsy.
AEDs are associated with an increased risk of osteoporosis 25 and osteoporotic-related fractures including hip, vertebral, and wrist/distal forearm. 7, 10, 16 Our results confirm the association of AED and increased risk with vertebral 7, 10, 16, 26, 27 and ankle fractures 28 but not with hip and wrist fractures, which may be due to the younger age of our cohort than previous studies. Few studies have assessed clavicular fractures. A smaller study investigating extremity fractures in epilepsy patients with a median age close to that of our AED users also identified an increased fracture risk within the previous 5 years of AED use. 15 Previous studies reported that fracture risk increased with AED polytherapy, 16, 25 with conflicting findings about therapy duration. 8, 9 We found an association of fracture risk with age, polytherapy, and treatment duration, but only the latter independently predicted fracture risk in users. Studies of fracture risk with AED use have mostly been conducted in older people, 16 particularly postmenopausal women, 7 due to their increased osteoporotic fracture risk. 29 Our study included younger patients (median age 39 years), seeking evidence of an earlier increase in fracture risk than previously reported. 28 We found a higher proportion of female users than nonusers had 1 or more falls in the preceding year. AED use is associated with multiple falls in older females, 7 and AED polytherapy is associated with increased sway (a risk factor for falls). 5, 30 Potential risk factors investigated in our study (age, AED polytherapy, duration of therapy) were not associated with non-seizure falls. Our data suggest that falls occur in both younger and older female users. We found that AED users taking antidepressants had an increased risk of falls compared to users who were not. Another study reported that older women using CNS-active medications including AEDs and antidepressants had an increased risk of recurrent falls. 31 Interactions between antidepressants and AEDs may magnify the risk for falls, and warrant further investigation.
Most of the reported falls in this study occurred during normal daily activities, with minimal or no warning, and most did not involve obstacles. This is consistent with AED effects on the CNS causing sedation, dizziness, unsteady gait, 6, 32, 33 and potentially cerebellar atrophy. 34 Many users (45%) suffered injuries from falls, 39% reduced normal activities, but only 24% sought medical attention, suggesting that many consider falls unavoidable. Nonetheless, these are clinically important events, as previous falls are a strong predictor of future falls. 31 Evidence shows that falls can be reduced in older people with single and multifactorial interventions, 35 although there are no randomized trials evaluating falls prevention interventions in epilepsy patients taking AEDs.
In our study, AED users in the preceding year had a high fall rate but very few of these falls caused fractures. This high ratio of falls to fractures is consistent with another Australian study which found that, although older people who fell frequently were 3.35 times more likely to have a fracture than those who did not fall, not all people at high risk for falls were necessarily at high risk of skeletal fragility. 36 Our findings suggest a complex relationship between increased falls and fractures with AED use.
We acknowledge limitations in our study. The ratio of age-matched controls for males (2.7:1) was less than for females (4:1), but was adjusted for in analysis. A lack of control data for falls restricted our comparative analysis to females. Falls in AED-treated males may be different and this requires investigation. Our sample size hindered meaningful subanalyses by specific AED type. Completing questionnaires while waiting in epilepsy clinics limited the questionnaire size so that potential confounders including smoking, alcohol use, vitamin D use, use of synthetic estrogen, physical activity, osteoprotective or psychotropic medications, or other sociodemographic factors were not collected, and therefore were not adjusted for in our analysis. Recall inaccuracy regarding falls and fractures may have occurred as the data were collected via self-report.
No published studies have explored the awareness of epilepsy patients about the effects of AEDs on bone health, fracture risk, and falls. Our study indicates that awareness of these issues is poor, despite our study population attending specialist epilepsy clinics at a center with a research interest in this area. Most patients (70%) indicated that they would like to be better informed about these issues, suggesting that more effective education strategies are not only warranted, but may also be well-received. 
